APA (7th ed.) Citation

WJ, C., A, B., K, C., G, A., L, C., & S, P. (2025). Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: An open-label extension study. Journal of Alzheimer's disease : JAD, 106(2), 783. https://doi.org/10.1177/13872877251345162

Chicago Style (17th ed.) Citation

WJ, Cubała, Berrio A, Chi-Burris K, Alva G, Chrones L, and Pathak S. "Pimavanserin Safety in Adult and Elderly Patients with Neuropsychiatric Symptoms Related to Neurodegenerative Disease: An Open-label Extension Study." Journal of Alzheimer's Disease : JAD 106, no. 2 (2025): 783. https://doi.org/10.1177/13872877251345162.

MLA (9th ed.) Citation

WJ, Cubała, et al. "Pimavanserin Safety in Adult and Elderly Patients with Neuropsychiatric Symptoms Related to Neurodegenerative Disease: An Open-label Extension Study." Journal of Alzheimer's Disease : JAD, vol. 106, no. 2, 2025, p. 783, https://doi.org/10.1177/13872877251345162.